MCID: PRM020
MIFTS: 39

Premenstrual Tension

Categories: Reproductive diseases

Aliases & Classifications for Premenstrual Tension

MalaCards integrated aliases for Premenstrual Tension:

Name: Premenstrual Tension 12 15 70
Premenstrual Syndrome 44 62 70

Classifications:



External Ids:

Disease Ontology 12 DOID:727
ICD9CM 34 625.4
MeSH 44 D011293
SNOMED-CT 67 123076003
ICD10 32 N94.3
UMLS 70 C0033046 C0376356

Summaries for Premenstrual Tension

PubMed Health : 62 About premenstrual syndrome: In the days leading up to their period, many women experience abdominal pain or a headache, are sad and irritable or feel bloated and generally uncomfortable. The medical term for this is “premenstrual syndrome” (PMS), also known as “premenstrual tension” (PMT). PMS symptoms are usually not very severe, and most women cope well with them. But in some women it is so bad that they are unable to go about their everyday lives during that time. Various treatments and measures can help to relieve PMS.

MalaCards based summary : Premenstrual Tension, also known as premenstrual syndrome, is related to neurotic disorder and endogenous depression, and has symptoms including pelvic pain, pain and other symptoms associated with female genital organs and mittelschmerz. An important gene associated with Premenstrual Tension is GNRH1 (Gonadotropin Releasing Hormone 1), and among its related pathways/superpathways is Antipsychotics Pathway (Metabolic Side Effects), Pharmacodynamics. The drugs Polyestradiol phosphate and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include skin, pituitary and ovary.

Wikipedia : 73 Premenstrual syndrome (PMS) refers to emotional and physical symptoms that regularly occur in the one to... more...

Related Diseases for Premenstrual Tension

Diseases related to Premenstrual Tension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 181)
# Related Disease Score Top Affiliating Genes
1 neurotic disorder 30.2 POMC LIPN
2 endogenous depression 30.2 POMC GNRH1
3 migraine with or without aura 1 30.0 REN POMC MTRNR2L5 LIPN
4 sexual disorder 30.0 REN POMC GNRH1
5 hyperprolactinemia 30.0 POMC GNRH1
6 amenorrhea 30.0 POMC GNRH1
7 estrogen excess 29.9 PGR GNRH1
8 hypothyroidism 29.6 REN POMC GNRH1
9 ovarian disease 29.1 REN POMC PGR GNRH1
10 disease of mental health 28.4 SP6 REN POMC PGR LIPN GNRH1
11 mood disorder 10.4
12 postpartum depression 10.3
13 pituitary infarct 10.2 POMC GNRH1
14 bell's palsy 10.2 MTRNR2L5 LIPN
15 hypothalamic disease 10.2 POMC GNRH1
16 facial nerve disease 10.2 MTRNR2L5 LIPN
17 pituitary apoplexy 10.2 POMC GNRH1
18 empty sella syndrome 10.2 POMC GNRH1
19 facial paralysis 10.2 MTRNR2L5 LIPN
20 van maldergem syndrome 1 10.2 POMC GNRH1
21 bipolar disorder 10.2
22 adrenal hypoplasia, congenital 10.2 POMC GNRH1
23 diabetes insipidus, neurohypophyseal 10.2 POMC GNRH1
24 sebaceous gland disease 10.2 POMC GNRH1
25 precocious puberty, male-limited 10.2 POMC GNRH1
26 acth-independent macronodular adrenal hyperplasia 10.2 POMC GNRH1
27 diffuse peritoneal leiomyomatosis 10.2 PGR GNRH1
28 leiomyomatosis 10.2 PGR GNRH1
29 anxiety 10.2
30 major affective disorder 8 10.2
31 major affective disorder 9 10.2
32 rickets 10.2
33 hypoglycemia 10.2
34 peritoneal benign neoplasm 10.2 PGR GNRH1
35 pyometritis 10.2 PGR GNRH1
36 adenomyoma 10.2 PGR GNRH1
37 vaginal discharge 10.2 PGR GNRH1
38 pain agnosia 10.1 POMC LIPN
39 agnosia 10.1 POMC LIPN
40 endometriosis of ovary 10.1 PGR GNRH1
41 endometrial disease 10.1 PGR GNRH1
42 obsessive-compulsive disorder 10.1
43 generalized anxiety disorder 10.1
44 breast disease 10.1
45 panic disorder 10.1
46 acne 10.1
47 irritable bowel syndrome 10.1
48 uterine benign neoplasm 10.1 PGR GNRH1
49 reproductive organ benign neoplasm 10.1 PGR GNRH1
50 disorder of sexual development 10.1 POMC GNRH1

Graphical network of the top 20 diseases related to Premenstrual Tension:



Diseases related to Premenstrual Tension

Symptoms & Phenotypes for Premenstrual Tension

UMLS symptoms related to Premenstrual Tension:


pelvic pain; pain and other symptoms associated with female genital organs; mittelschmerz; unspecified symptom associated with female genital organs; other specified symptoms associated with female genital organs; female genital pain and other symptoms

Drugs & Therapeutics for Premenstrual Tension

PubMed Health treatment related to Premenstrual Tension: 62

There isn’t much good research on what can help reduce PMS. So it isn’t clear how effective many of the PMS treatments are. Girls and women with PMS often try out different things to reduce their symptoms. For instance, some women with mild PMS try out relaxation techniques, acupuncture , getting more exercise , drinking less alcohol and coffee, or eating less salt. Others use herbal products and dietary supplements such as chaste tree extracts (Vitex agnus castus), St. John’s wort, calcium or pyridoxine vitamin B6 ). More severe PMS can be treated with a number of medications. But many of these medications haven’t been approved for the treatment of PMS, and they can have side effects: Hormone medications like the birth control pill or hormone patches affect women’s hormone levels and lead to an improvement in PMS or PMDD. Antidepressants : SSRIs (selective serotonin reuptake inhibitors ) can help reduce severe psychological problems caused by PMS or PMDD. Painkillers can effectively relieve severe period pain and are usually well tolerated. There is very little research on whether they also help in PMS, though. Women who have problems with PMS-related water retention can take diuretics (water pills ) . If PMS causes psychological problems, cognitive behavioral therapy (CBT) is an option. But it isn’t clear whether it helps in PMS.

Drugs for Premenstrual Tension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 109)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Polyestradiol phosphate Approved Phase 4 28014-46-2
2
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
3
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
4
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
5
Leuprolide Approved, Investigational Phase 4 53714-56-0 3911 657181
6
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
7
Drospirenone Approved Phase 4 67392-87-4 68873
8
Sertraline Approved Phase 4 79617-96-2 68617
9
Flutamide Approved, Investigational Phase 4 13311-84-7 3397
10
Desogestrel Approved Phase 4 54024-22-5 40973
11
Salmon calcitonin Approved, Investigational Phase 4 47931-85-1 16129616
12
Epoprostenol Approved Phase 4 61849-14-7, 35121-78-9 5280427 5282411
13
Dinoprostone Approved Phase 4 363-24-6 5280360
14
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
15
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
16
Sumatriptan Approved, Investigational Phase 4 103628-46-2 5358
17
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
18
Citalopram Approved Phase 4 59729-33-8 2771
19
Tezosentan Investigational Phase 4 180384-57-0
20
Calcitonin gene-related peptide Investigational Phase 4 83652-28-2
21
Dexetimide Withdrawn Phase 4 21888-98-2
22 Hormones Phase 4
23 Hormone Antagonists Phase 4
24 Antineoplastic Agents, Hormonal Phase 4
25 Estrogens Phase 4
26 Contraceptive Agents Phase 4
27 Estradiol 3-benzoate Phase 4
28 Estradiol 17 beta-cypionate Phase 4
29 Contraceptives, Oral Phase 4
30 Antirheumatic Agents Phase 4
31 Analgesics, Non-Narcotic Phase 4
32 Anti-Inflammatory Agents Phase 4
33 Anti-Inflammatory Agents, Non-Steroidal Phase 4
34 Analgesics Phase 4
35 Drospirenone and ethinyl estradiol combination Phase 4
36 Cyclooxygenase Inhibitors Phase 4
37 Cytochrome P-450 Enzyme Inhibitors Phase 4
38 Progestins Phase 4
39 Contraceptives, Oral, Combined Phase 4
40 Androgens Phase 4
41 Androgen Antagonists Phase 4
42 Mineralocorticoid Receptor Antagonists Phase 4
43 Diuretics, Potassium Sparing Phase 4
44 Mineralocorticoids Phase 4
45 diuretics Phase 4
46 Dacuronium Phase 4
47 Vasoconstrictor Agents Phase 4
48 Katacalcin Phase 4
49 Serotonin 5-HT1 Receptor Agonists Phase 4
50 Hydrocortisone hemisuccinate Phase 4

Interventional clinical trials:

(show top 50) (show all 65)
# Name Status NCT ID Phase Drugs
1 Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives. Unknown status NCT01251263 Phase 4 Estradiol or Placebo;Estradiol or Placebo
2 Understanding Experimentally Induced Hot Flushes and Their Impact on Sleep and Mood Completed NCT00455689 Phase 4 Leuprolide acetate
3 Androgen Hormones in PMDD Completed NCT00611923 Phase 4 Flutamide;Placebo
4 Short-Term Versus Long-Term Treatment for Severe PMS Completed NCT00318773 Phase 4 sertraline
5 A Comparative Efficacy of Low-dose Combine Oral Contraceptives Containing Desogestrel 150 mg and Drospirenone 3 mg on Premenstrual Symptoms Completed NCT01482338 Phase 4 EE 20 microgram with desogestrel 150 mg;EE 20 microgram with drospirenone 3 mg
6 Evaluation of CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Saliva of Menstrual Migraine Patients Before and After Treatment With Treximet™ Completed NCT01329562 Phase 4 Treximet;Placebo
7 The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder Completed NCT00678574 Phase 4 fluoxetine
8 A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine When Used for the Treatment of Premenstrual Dysphoria Completed NCT00516113 Phase 4 paroxetine
9 Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment)Of Menstrual Migraine Completed NCT00904098 Phase 4 Frovatriptan;Usual Care
10 An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine Completed NCT01578941 Phase 4
11 Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study Terminated NCT00523705 Phase 4 escitalopram
12 EnBrace HR for Premenstrual Syndrome (PMS) With Prominent Mood Symptoms (or Menstrual Related Mood Disorders, MRMD) Withdrawn NCT04123483 Phase 4 EnBrace HR Softgel
13 Is Homeopathic Treatment a Placebo Treatment? - Homeopathic Treatment of Premenstrual Syndrome- A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial Unknown status NCT02402049 Phase 3 Natrum muriaticum 30C;Lachesis 30C;Sepia 30C;Nux vomica 30C;Pulsatilla 30C;Folliculinum 30C;Placebo Natrum muriaticum;Placebo Lachesis;Placebo Sepia;Placebo Nux vomica;Placebo pulsatilla;Placebo Folliculinum
14 Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study. Unknown status NCT02562053 Phase 3 Fluoxetine;Combined oral contraceptives;Placebo 1;Placebo 2
15 The Synergistic Use of Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in the Management of Severe Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial Unknown status NCT02488538 Phase 3 Combined oral contraceptives;Fluoxetine;Combined oral contraceptives placebo;Fluoxetine placebo
16 Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms Unknown status NCT01365676 Phase 3 GAMALINE® + HIPERICIN®;GAMALINE®
17 The Effect of Toremifene Treatment to the Magnetic Resonance Imaging Findings in Women Suffering From Premenstrual Mastalgia Completed NCT00534846 Phase 3 toremifene;placebo
18 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms Completed NCT00161681 Phase 3 Levonorgestrel/Ethinyl Estradiol
19 Double-blind Comparison of VAC BNO 1095 Film Coated Tablets With Placebo to Identify Dose Dependent Effects in Patients Suffering From Cyclic Mastodynia and Premenstrual Syndrome Completed NCT01309113 Phase 3 VAC BNO 1095 film coated tablets
20 Calcium Supplements Versus Oral Contraceptive Pills Containing Drospirenone in Treating Mild to Moderate Premenstrual Syndrome: A Double Blind Randomized Placebo Controlled Trial Completed NCT02089620 Phase 3 Yasmin;Placebo 1;Placebo 2
21 The Impact of Sérélys PMS, a Herbal Remedy Based on Pollen Extraction and Saffron, on Symptoms of PMS: A Randomized, Double-blinded, Placebo Controlled Study Completed NCT03298607 Phase 3
22 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder Completed NCT00195559 Phase 3 Levonorgestrel/Ethinyl Estradiol
23 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder Completed NCT00128934 Phase 3 levonorgestrel/ethinyl estradiol
24 Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial Recruiting NCT02427334 Phase 3 Dienogest;Fluoxetine;Placebo
25 Prospective, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Randomized Clinical Trial to Proof Efficacy and Safety of 20 mg (2 Tablets of 10 mg) VAC BNO 1095 FCT in Patients Suffering From Cyclic Mastodynia and PMS Terminated NCT01870687 Phase 3 20mg VAC BNO 1095 FCT;Placebo
26 A Phase II Randomized, Two-arms, Single-blind, Cross Controlled Study for Evaluation the Safety and Efficacy of Diagnosis and Treatment of Premenstrual Syndrome by Detecting Skin Reactions Followed by Desensitization to Sex Hormones Unknown status NCT00873262 Phase 2 Skin test panel and desensitization kit;Skin test panel and solvent
27 Prospective, Controlled, Single-blinded, Longitudinal, Two-arms, Clinical Study Evaluation of Efficacy/Safety of EVE-PMS Skin-Test Panel -Detecting Sensitivity to Sex Hormones in Women With Premenstrual Syndrome Unknown status NCT00866437 Phase 2 Skin test panel;Skin test panel
28 The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome Completed NCT02481973 Phase 2
29 a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS) Completed NCT00672607 Phase 2 extracts of Vitex agnus castus tablets;Placebo
30 An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome in Indian Females Completed NCT02467088 Phase 2
31 Auriculotherapy in the Cares to the Premenstrual Syndrome: Randomized Clinical Trial Completed NCT01782040 Phase 2
32 Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder Completed NCT00048854 Phase 1, Phase 2 Sertraline
33 An Exploratory Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine Active, not recruiting NCT04102995 Phase 2 Sepranolone injection low dose;Sepranolone injection high dose;Placebo injection
34 The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives Terminated NCT00089414 Phase 2 Ethinyl Estradiol/Drospirenone;Placebo;CDB 2914
35 The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron) Completed NCT00001259 Phase 1 Leuprolide;Estradiol Patches;Progesterone
36 The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls Completed NCT00082043 Phase 1 Dutasteride;Placebo oral capsule
37 The Study of Efficacy and Effect of Different Dose Acupuncture on Autonomic Nervous Activity and Quality of Life in Women With Dysmenorrhea Unknown status NCT03881319 Conventional gynecologic treatment
38 The Symptom Experience of Women With Perimenstrual Syndrome;Women's Health Related Quality of Life. Unknown status NCT00174161
39 Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine Unknown status NCT02592681
40 Evaluating Treatment With Homeopathy, Acupuncture, and Anthroposophic Medicine in Improving the Quality of Life for Women Treated at the Public Unified Healthcare System Unknown status NCT02504515
41 Detecting Auricular Points Among Patients With Menstrual Migraine by A Novel Auricular Point Detector (APD): A Pilot Diagnostic Accuracy Study Unknown status NCT03702114
42 Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome Completed NCT02809066
43 Effect of Zumba Dance on Premenstrual Tension:8 Weeks Randomized Controlled Trial Completed NCT03529721
44 Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome Completed NCT04610957 Rosafem (FEMININE FORMULA)
45 Prevalence of Self-reported Premenstrual Syndrome and Analysis of Somatic and Psychoemotional Symptoms in Brazilian Women Aged 20 to 49 Years Completed NCT04455685
46 A Double-blind, Parallel Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS) Completed NCT00965562 Fluoxetine;Calcium;Placebo
47 Foot Reflexology Combined With Dietary Modification on Premenstrual Syndrome Completed NCT04348201
48 Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS) Completed NCT01961479
49 Effects of Aerobic Exercise on the Symptoms of Premenstrual Syndrome and Dysmenorrhoea and Blood Flow of Genital Tract: A Prospective Interventional Study Completed NCT04618172
50 Effect of Aeropbic Exercise as Swimming on Premenstrual Syndrome Completed NCT03264612

Search NIH Clinical Center for Premenstrual Tension

Inferred drug relations via UMLS 70 / NDF-RT 51 :


Ibuprofen
Mefenamic Acid
pamabrom
solufenum

Cochrane evidence based reviews: premenstrual syndrome

Genetic Tests for Premenstrual Tension

Anatomical Context for Premenstrual Tension

MalaCards organs/tissues related to Premenstrual Tension:

40
Skin, Pituitary, Ovary, Cortex, Brain, Eye, Liver

Publications for Premenstrual Tension

Articles related to Premenstrual Tension:

(show top 50) (show all 2739)
# Title Authors PMID Year
1
The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. 61 54
10368798 1999
2
Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. 54 61
9230648 1997
3
Clinical applications of GnRH and its analogues. 54 61
18407075 1992
4
Association of Premenstrual Dysphoric Disorder and Eating Behaviors Among Nursing Students: A Cross-Sectional Study. 61
33271293 2021
5
The reliability and validity of the Japanese version of the Daily Record of Severity of Problems (J-DRSP) and Development of a Short-Form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women. 61
33736660 2021
6
Premenstrual syndrome, a common but underrated entity: Review of the clinical literature. 61
33663193 2021
7
A comparison between the effects of school-based education programs provided by peer group versus health practitioners on premenstrual syndrome in adolescents: A protocol for a non-masked clinical trial. 61
33715300 2021
8
BNO 1095, a Standardized Dry Extract from the Fruits of Vitex agnus-castus, Impairs Angiogenesis-related Endothelial Cell Functions In Vitro. 61
33530113 2021
9
The effects of acupressure and yoga for coping with premenstrual syndromes on premenstrual symptoms and quality of life. 61
33310053 2021
10
Serum antioxidant vitamin concentrations and oxidative stress markers associated with symptoms and severity of premenstrual syndrome: a prospective cohort study. 61
33530988 2021
11
Pubertal development and risk of premenstrual disorders in young adulthood. 61
33289027 2021
12
Addictive behaviors across the menstrual cycle: a systematic review. 61
33404701 2021
13
The association between menstrual symptoms and hypertension among young women: A prospective longitudinal study. 61
33308624 2021
14
Female Military Officers Report a Desire for Menstrual Suppression During Military Training. 61
33499478 2021
15
[Healthcare for premenstrual discomfort patients. Women's perspective]. 61
33309433 2021
16
Association between Childhood Maltreatment History and Premenstrual Syndrome. 61
33477613 2021
17
The effects of psychoeducation based on the cognitive-behavioral approach on premenstrual syndrome symptoms: A randomized controlled trial. 61
32538501 2021
18
The effects of health belief model-based education and acupressure for coping with premenstrual syndrome on premenstrual symptoms and quality of life: A randomized-controlled trial. 61
32468669 2021
19
Premenstrual Syndrome and Female Sexual Function. 61
33302813 2021
20
Does premenstrual syndrome before pregnancy increase the risk of postpartum depression? Findings from the Australian Longitudinal Study on Women's Health. 61
33049432 2021
21
A Japanese herbal medicine attenuates anxiety-like behavior through GABAA receptor and brain-derived neurotrophic factor expression in a rat model of premenstrual syndrome. 61
33357772 2021
22
Analysis of 3702 patients with acne vulgaris and concomitant comorbidities in Turkey: a multi-centered, prospective, controlled study. 61
33471379 2021
23
Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women. 61
33430265 2021
24
[Menstrual disorders: what we know about dietary-nutritional therapy]. 61
32993311 2021
25
Sleep disturbance is associated with an increased risk of menstrual problems in female Chinese university students. 61
32445135 2020
26
Regulated aberrant amygdala functional connectivity in premenstrual syndrome via electro-acupuncture stimulation at sanyinjiao acupoint(SP6). 61
33307896 2020
27
Neural evidence of dysfunction of reward processing in women with premenstrual syndrome. 61
33160966 2020
28
A forced swim-based rat model of premenstrual depression: effects of hormonal changes and drug intervention. 61
33229622 2020
29
Effect of pilates exercises on premenstrual syndrome symptoms: a quasi-experimental study. 61
33246104 2020
30
Association of socio-demographic, dietary and lifestyle factors with Premenstrual Syndrome (PMS) among undergraduate medical students of a tertiary care institute in Ahmedabad, Gujarat. 61
33532420 2020
31
Prevalence of Premenstrual Syndrome Levels and Its Management Among Female Students of Medical and Non-Medical Colleges in Riyadh. 61
33240729 2020
32
Progesterone - Friend or foe? 61
32730861 2020
33
Menstrual Cycle Modulates Motor Learning and Memory Consolidation in Humans. 61
33019607 2020
34
Childhood Trauma and Premenstrual Symptoms: The Role of Emotion Regulation. 61
32768748 2020
35
Premenstrual disorders among young Turkish women: According to DSM-IV and DSM-V criteria using the premenstrual symptoms screening tool. 61
33111372 2020
36
Physical and Psychological Symptoms Associated With Premenstrual Syndrome and Their Impact on the Daily Routine of Women in a Low Socioeconomic Status Locality. 61
33173629 2020
37
Neuropsychological function is related to irritable bowel syndrome in women with premenstrual syndrome and dysmenorrhea. 61
32594296 2020
38
Are premenstrual syndrome and dysmenorrhea related to the personality structure of women? A descriptive relation-seeker type study. 61
32488914 2020
39
Traditional Chinese medicine on treating premenstrual syndrome and premenstrual dysphoric disorder: A protocol for systematic review and meta-analysis. 61
33080718 2020
40
Biomarker validation of a new case definition of menstrual cycleassociated syndrome (MCAS) Opinion Paper. 61
32998680 2020
41
Effect of zinc supplementation on quality of life and sleep quality in young women with premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. 61
32514756 2020
42
Relationship between premenstrual syndrome and sleep quality among nursing and medical students. 61
32984973 2020
43
Effectiveness of Echium amoenum on premenstrual syndrome: a randomized, double-blind, controlled trial. 61
32993653 2020
44
Effect of exercise on symptoms of premenstrual syndrome in low and middle-income countries: a protocol for systematic review and meta-analysis. 61
32998927 2020
45
The impact of dysmenorrhea and premenstrual syndrome on academic performance of college students, and their willingness to seek help. 61
33072424 2020
46
Association of fine-particulate and acidic-gas air pollution with premenstrual syndrome risk. 61
32186731 2020
47
CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders. 61
32887304 2020
48
Full Remission of Long-Term Premenstrual Dysphoric Disorder-Like Symptoms Following Resection of a Pituitary Adenoma: Case Report. 61
32769963 2020
49
The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones. 61
32526539 2020
50
Exercise for premenstrual syndrome: a systematic review and meta-analysis of randomised controlled trials. 61
32522750 2020

Variations for Premenstrual Tension

Expression for Premenstrual Tension

Search GEO for disease gene expression data for Premenstrual Tension.

Pathways for Premenstrual Tension

Pathways related to Premenstrual Tension according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.92 POMC ANKK1

GO Terms for Premenstrual Tension

Biological processes related to Premenstrual Tension according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of blood pressure GO:0008217 8.96 REN POMC
2 cell-cell signaling GO:0007267 8.8 POMC PGR GNRH1

Sources for Premenstrual Tension

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....